Geneva, October 31, 2012

Panel II: “Creative Innovation: Addressing Key Research Gaps”

Ama de-Graft Aikins, Visiting Fellow, London School of Economics, Health
Francis Gurry, Director General, World Intellectual Property Organization
Trevor Mundel, President, Global Health Program, Gates Foundation
Dhaval D Patel, Head, Novartis Institutes for BioMedical Research Europe, Novartis
Bernard Pécoul, Executive Director, Drugs for Neglected Diseases Initiative
Ulf Wiinberg, President and CEO, Lundbeck

About IFPMA

IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.

To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.

ifpma.org

Media Contact

Elliot Dunster e.dunster@ifpma.org